Articulus Surgical Private Limited

Articulus Surgical Private Limited, based in Bengaluru, India, focuses on developing advanced robotic surgical systems to enhance surgical precision and flexibility, specifically targeting the needs of modern surgical practices. Articulus Surgical Private Limited is committed to designing cutting-edge robotic surgical solutions. Founded in 2020 in Bengaluru, India, the company has completed 2 deals to date, with the most recent deal occurring on February 11, 2026. The company is led by a team of experienced professionals, yet specific details about the founder or CEO have not been disclosed.

Articulus Surgical specializes in the development of advanced robotic surgical systems, notably the Articulus Pulsar Surgical Robotics system, which is currently under development and not yet available for clinical use. This system is designed to enhance surgical precision, flexibility, and control, addressing critical needs in modern surgical practice. Its functionality allows for independent or interoperable use with existing medical infrastructure, thereby accommodating diverse operational environments in hospitals and clinics. The intended end users are surgeons and medical staff across various specialties, including but not limited to urology and general surgery.

The primary geographical markets targeted for these products include India and other emerging healthcare markets, where the demand for cost-effective technological solutions in surgical procedures is on the rise. The revenue model for Articulus Surgical revolves around direct sales and potential partnerships with healthcare institutions. Clients, primarily hospitals and surgical centers, engage with the company to procure the Articulus Pulsar system, which is expected to be sold through B2B transactions. The company's revenue is anticipated to be generated from the sale of robotic systems as well as ongoing service agreements related to the maintenance and support of these technologies.

While specific pricing plans are not disclosed, the structure likely includes one-time capital expenditures for the initial purchase of the robotic systems, along with additional operational service fees. The emphasis on affordability aims to alleviate financial burdens on healthcare providers, thereby supporting the adoption of robotic surgery solutions in various clinical settings. Articulus Surgical plans to leverage its most recent seed funding round in February 2026 from Kalaari Capital to further develop its Articulus Pulsar Surgical Robotics system and expedite its market launch. In addition to enhancing product capabilities, the company aims to expand its reach into other emerging healthcare markets beyond India by 2027, catering to the growing demand for advanced surgical technologies.

The focus will be on ensuring that their solutions are affordable and accessible, thereby supporting healthcare providers in improving surgical outcomes.